Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Pharma
UPDATED: FDA advisers back Carvykti, Abecma in earlier myeloma
The FDA's outside advisers voted that the early deaths seen in the two CAR-Ts' trials are an acceptable risk compared to the drugs' benefits.
Angus Liu
Mar 15, 2024 1:58pm
BIO-WuXi, Takeda, FDA-Carvykti—Fierce Pharma Asia
Mar 15, 2024 10:15am
Bristol Myers bags FDA nod to bring CAR-T to CLL
Mar 15, 2024 9:46am
FDA flags early deaths for multiple myeloma CAR-Ts
Mar 13, 2024 11:06am
Legend CEO offers preview of high-stakes FDA adcomm for Carvykti
Mar 11, 2024 1:29pm
CAR-T boxed warnings: What comes next?
Mar 1, 2024 8:47am